Forme galénique: Stylo injecteur pour l'auto-administration sous-cutanée, compatible avec les cartouches de 1,5 mL et 3,0 mL
Indication thérapeutique: Destiné à l'auto-administration de médicaments injectables tels que l'insuline, les traitements GLP-1, l'hormone de croissance, les traitements de la fertilité et de l'ostéoporose
Conditionnement: Configuré pour des cartouches de 3,0 mL, la plateforme étant également conçue pour accueillir des cartouches de 1,5 mL

Autres informations

Description supplémentaire:

The Envoi Pen Injector is a compact, user-friendly device for subcutaneous self-administration of injectable medications, including insulin and GLP-1 drugs. As an addition to the Phillips Medisize portfolio, it helps biopharma companies roll out novel and generic drug treatments faster and at scale. It combines a compact design (about 152 mm long) with the ability to deliver up to 80 IU in a single injection, a limited plunger travel (about 33 mm) for maximum dosing, ease of use for people with small hands or dexterity challenges, a flexible design for both fixed and variable dosing, and relatively low dosing force. It is designed for 3.0 ml and 1.5 ml cartridges, with an easy-to-scale platform currently available for 3 ml cartridges, serving patients managing diabetes, growth hormone therapy, fertility treatment, and osteoporosis.